• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Use of SSRIs may Impact Bone Density in Adolescent and Young Women with Anorexia Nervosa.使用选择性5-羟色胺再摄取抑制剂(SSRI)可能会影响患有神经性厌食症的青少年及年轻女性的骨密度。
CNS Spectr. 2010 Sep;15(9):579-586. doi: 10.1017/s1092852900000559.
2
Use of selective serotonin reuptake inhibitors and bone mass in adolescents: An NHANES study.青少年中选择性5-羟色胺再摄取抑制剂的使用与骨量:一项美国国家健康和营养检查调查研究
Bone. 2015 Sep;78:28-33. doi: 10.1016/j.bone.2015.04.042. Epub 2015 May 2.
3
Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis.选择性 5-羟色胺再摄取抑制剂对骨密度的影响:系统评价和荟萃分析。
Osteoporos Int. 2018 Jun;29(6):1243-1251. doi: 10.1007/s00198-018-4413-0. Epub 2018 Feb 12.
4
Selective determinants of low bone mineral mass in adult women with anorexia nervosa.选择性决定因素的低骨矿物质密度在成年女性与神经性厌食症。
Int J Endocrinol. 2013;2013:897193. doi: 10.1155/2013/897193. Epub 2013 Mar 24.
5
Impact of low-weight severity and menstrual status on bone in adolescent girls with anorexia nervosa.低体重严重程度和月经状况对神经性厌食症青春期女孩骨骼的影响。
Int J Eat Disord. 2017 Apr;50(4):359-369. doi: 10.1002/eat.22681. Epub 2017 Feb 2.
6
Examining Whether Genetic Variants Moderate the Skeletal Effects of Selective Serotonin Reuptake Inhibitors in Older Adolescents and Young Adults.探讨遗传变异是否调节选择性 5-羟色胺再摄取抑制剂对青少年和年轻成人骨骼的影响。
J Child Adolesc Psychopharmacol. 2023 Sep;33(7):260-268. doi: 10.1089/cap.2023.0007. Epub 2023 Aug 9.
7
Plasma sodium level is associated with bone loss severity in women with anorexia nervosa: a cross-sectional study.血浆钠水平与神经性厌食症女性骨丢失严重程度相关:一项横断面研究。
J Clin Psychiatry. 2012 Nov;73(11):e1379-83. doi: 10.4088/JCP.12m07919.
8
Comparisons of bone density and body composition among adolescents with anorexia nervosa and atypical anorexia nervosa.比较神经性厌食症和非典型神经性厌食症青少年的骨密度和身体成分。
Int J Eat Disord. 2019 May;52(5):591-596. doi: 10.1002/eat.23048. Epub 2019 Feb 16.
9
Variants of the serotonin transporter gene, selective serotonin reuptake inhibitors, and bone mineral density in risperidone-treated boys: a reanalysis of data from a cross-sectional study with emphasis on pharmacogenetics.血清素转运体基因变体、选择性 5-羟色胺再摄取抑制剂与利培酮治疗男孩的骨密度:一项基于药物遗传学的重点为横断面研究数据的再分析。
J Clin Psychiatry. 2011 Dec;72(12):1685-90. doi: 10.4088/JCP.10m06198.
10
Regional fat depots and their relationship to bone density and microarchitecture in young oligo-amenorrheic athletes.年轻的少经运动员的局部脂肪储存及其与骨密度和骨微结构的关系。
Bone. 2015 Aug;77:83-90. doi: 10.1016/j.bone.2015.04.005. Epub 2015 Apr 10.

引用本文的文献

1
Transition of young adults with metabolic bone diseases to adult care.代谢性骨病青年患者向成人医疗的过渡。
Front Endocrinol (Lausanne). 2023 Mar 17;14:1137976. doi: 10.3389/fendo.2023.1137976. eCollection 2023.
2
The use of antidepressants is linked to bone loss: A systematic review and metanalysis.抗抑郁药的使用与骨质流失有关:一项系统评价和荟萃分析。
Orthop Rev (Pavia). 2022 Oct 13;14(6):38564. doi: 10.52965/001c.38564. eCollection 2022.
3
Absence of relationships between depression and anxiety and bone mineral density in patients hospitalized for severe anorexia nervosa.住院治疗的严重神经性厌食症患者中,抑郁和焦虑与骨密度之间无关联。
Eat Weight Disord. 2021 Aug;26(6):1975-1984. doi: 10.1007/s40519-020-01045-9. Epub 2020 Oct 21.
4
Anorexia Nervosa and Bone.神经性厌食症与骨骼
Curr Opin Endocr Metab Res. 2018 Dec;3:74-82. doi: 10.1016/j.coemr.2018.01.002. Epub 2018 Jan 31.
5
Medication in AN: A Multidisciplinary Overview of Meta-Analyses and Systematic Reviews.神经性厌食症的药物治疗:荟萃分析与系统评价的多学科概述
J Clin Med. 2019 Feb 25;8(2):278. doi: 10.3390/jcm8020278.
6
The Impact of Psychotropic Medications on Bone Health in Youth.精神类药物对青少年骨骼健康的影响。
Curr Psychiatry Rep. 2018 Sep 24;20(11):104. doi: 10.1007/s11920-018-0960-5.
7
Effects of Anorexia Nervosa on Bone Metabolism.神经性厌食症对骨代谢的影响。
Endocr Rev. 2018 Dec 1;39(6):895-910. doi: 10.1210/er.2018-00063.
8
Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis.选择性 5-羟色胺再摄取抑制剂对骨密度的影响:系统评价和荟萃分析。
Osteoporos Int. 2018 Jun;29(6):1243-1251. doi: 10.1007/s00198-018-4413-0. Epub 2018 Feb 12.
9
Eating disorders and bone metabolism in women.女性的饮食失调与骨代谢
Curr Opin Pediatr. 2017 Aug;29(4):488-496. doi: 10.1097/MOP.0000000000000508.
10
Serotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effect.血清素再摄取抑制剂通过抵消局部抗吸收作用在小鼠体内产生中枢性骨质流失。
Nat Med. 2016 Oct;22(10):1170-1179. doi: 10.1038/nm.4166. Epub 2016 Sep 5.

本文引用的文献

1
Effects of rhIGF-1 administration on surrogate markers of bone turnover in adolescents with anorexia nervosa.重组人胰岛素样生长因子-1(rhIGF-1)给药对神经性厌食症青少年骨转换替代标志物的影响。
Bone. 2009 Sep;45(3):493-8. doi: 10.1016/j.bone.2009.06.002. Epub 2009 Jun 10.
2
Linking chronic tryptophan deficiency with impaired bone metabolism and reduced bone accrual in growing rats.将慢性色氨酸缺乏与生长中大鼠的骨代谢受损及骨量积累减少联系起来。
J Cell Biochem. 2009 Aug 1;107(5):890-8. doi: 10.1002/jcb.22189.
3
Adrenal glucocorticoid and androgen precursor dissociation in anorexia nervosa.神经性厌食症中肾上腺糖皮质激素与雄激素前体的解离
J Clin Endocrinol Metab. 2009 Apr;94(4):1367-71. doi: 10.1210/jc.2008-2558. Epub 2009 Jan 21.
4
Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum.Lrp5通过抑制十二指肠中血清素的合成来控制骨形成。
Cell. 2008 Nov 28;135(5):825-37. doi: 10.1016/j.cell.2008.09.059.
5
Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures.选择性5-羟色胺再摄取抑制剂类抗抑郁药与非椎骨骨折风险增加有关。
J Clin Psychopharmacol. 2008 Aug;28(4):411-7. doi: 10.1097/JCP.0b013e31817e0ecb.
6
Fracture risk from psychotropic medications: a population-based analysis.精神药物导致的骨折风险:一项基于人群的分析。
J Clin Psychopharmacol. 2008 Aug;28(4):384-91. doi: 10.1097/JCP.0b013e31817d5943.
7
Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa.神经性厌食症女性的肽YY(PYY)水平与骨密度(BMD)
Bone. 2008 Jul;43(1):135-139. doi: 10.1016/j.bone.2008.03.007. Epub 2008 Mar 25.
8
Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression.有抑郁症病史女性使用选择性5-羟色胺再摄取抑制剂与骨矿物质密度的关系
Int Clin Psychopharmacol. 2008 Mar;23(2):84-7. doi: 10.1097/YIC.0b013e3282f2b3bb.
9
Depressive symptoms, bone loss, and fractures in postmenopausal women.绝经后女性的抑郁症状、骨质流失和骨折
J Gen Intern Med. 2008 May;23(5):567-74. doi: 10.1007/s11606-008-0525-0. Epub 2008 Feb 20.
10
Low bone mass in premenopausal women with depression.患有抑郁症的绝经前女性骨量低。
Arch Intern Med. 2007 Nov 26;167(21):2329-36. doi: 10.1001/archinte.167.21.2329.

使用选择性5-羟色胺再摄取抑制剂(SSRI)可能会影响患有神经性厌食症的青少年及年轻女性的骨密度。

Use of SSRIs may Impact Bone Density in Adolescent and Young Women with Anorexia Nervosa.

作者信息

Misra Madhusmita, Le Clair Marie, Mendes Nara, Miller Karen K, Lawson Elizabeth, Meenaghan Erinne, Weigel Thomas, Ebrahimi Seda, Herzog David B, Klibanski Anne

机构信息

Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114 ; Pediatric Endocrine Unit, Mass General Hospital for Children and Harvard Medical School, Boston, MA 02114.

Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.

出版信息

CNS Spectr. 2010 Sep;15(9):579-586. doi: 10.1017/s1092852900000559.

DOI:10.1017/s1092852900000559
PMID:24790401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4001118/
Abstract

OBJECTIVES

Alterations in serotonin impact bone metabolism in animal models, and selective serotonin reuptake inhibitors (SSRI) have been associated with increased fracture risk in older adults. SSRIs are commonly used in anorexia nervosa (AN), a condition that predisposes to low bone mineral density (BMD). Our objective was to determine whether SSRI use is associated with low BMD in AN.

METHODS

We examined Z-scores for spine, hip and whole body (WB) BMD, spine bone mineral apparent density and WBBMC/height (Ht) in females with AN 12-21 years old who had never been on SSRIs, on SSRIs for <6 months (<6M) or >6 months (>6M).

RESULTS

Subjects on SSRIs for >6M had lower spine, femoral-neck and WBBMD Z-scores than those on SSRIs for <6M. Hip BMD and WBBMC/Ht Z-scores were lowest in subjects on SSRIs for >6M. Duration of SSRI use, duration since AN diagnosis and duration of amenorrhea inversely predicted BMD, whereas BMI was a positive predictor. In a regression model, duration of SSRI use remained an independent negative predictor of BMD.

DISCUSSION

Duration of SSRI use >6M is associated with low BMD in AN.

CONCLUSION

It may be necessary to monitor BMD more rigorously when duration of SSRI use exceeds 6M.

摘要

目的

血清素的改变会影响动物模型中的骨代谢,且选择性血清素再摄取抑制剂(SSRI)与老年人骨折风险增加有关。SSRI常用于神经性厌食症(AN),这种疾病易导致低骨密度(BMD)。我们的目的是确定使用SSRI是否与AN患者的低BMD有关。

方法

我们检测了12至21岁从未使用过SSRI、使用SSRI少于6个月(<6M)或超过6个月(>6M)的AN女性患者的脊柱、髋部和全身(WB)BMD的Z值、脊柱骨矿物质表观密度以及WBBMC/身高(Ht)。

结果

使用SSRI超过6个月的受试者的脊柱、股骨颈和WBBMD Z值低于使用SSRI少于6个月的受试者。使用SSRI超过6个月的受试者的髋部BMD和WBBMC/Ht Z值最低。SSRI使用时间、自AN诊断以来的时间以及闭经时间与BMD呈负相关,而BMI是一个正相关预测因素。在回归模型中,SSRI使用时间仍然是BMD的独立负相关预测因素。

讨论

使用SSRI超过6个月与AN患者的低BMD有关。

结论

当SSRI使用时间超过6个月时,可能有必要更严格地监测BMD。